| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |